Latest news
ADHD: First New Drug Class in Decades Gets FDA Approval - DenkstromDenkstrom · Sat, 08 Aug 2026 00:15:45 GMTFDA Approves First-in-Class Centanafadine for ADHD in Adults and Pediatric Patients - Pharmacy TimesPharmacy Times · Mon, 03 Aug 2026 16:09:45 GMTA New Mechanism for ADHD: Raman Baweja, MD, on Centanafadine's FDA Approval - Psychiatric TimesPsychiatric Times · Fri, 31 Jul 2026 07:00:00 GMTACT Brief: Data Readiness Gap in Continuous Monitoring, Workflow-Centric AI Deployment, and First-in-Class ADHD Mechanism - Applied Clinical Trials OnlineApplied Clinical Trials Online · Tue, 28 Jul 2026 11:44:38 GMTFDA approves Otsuka’s ADHD drug Simtriyo, teeing up its ‘next major CNS launch’ - Fierce PharmaFierce Pharma · Mon, 27 Jul 2026 07:00:00 GMTFDA Approves First NDSRI for ADHD in Adults and Children - medscape.commedscape.com · Mon, 27 Jul 2026 07:00:00 GMTFDA Approves Centanafadine for ADHD: Who Qualifies, How It Differs, and What Side Effects Appeared - Medical DailyMedical Daily · Mon, 27 Jul 2026 07:00:00 GMT